FIELD: medicine.
SUBSTANCE: invention refers to a pharmaceutical composition for treating cataract, presented in the form of an ophthalmic ointment, characterised by the fact that it contains sodium dihydroazapentacene polysulphonate, a preserving agent and base components; the components of the composition are taken in certain ratio, wt %.
EFFECT: extending the range of products for treating cataract, stability and sterility after shelf life expiration.
2 tbl
Authors
Dates
2015-12-20—Published
2014-10-01—Filed